Health Canada says AstraZeneca COVID-19 vaccines from Baltimore plant safe

Health Canada says the 1.5 million doses of the AstraZeneca Plc COVID-19 vaccine imported from Emergent BioSolutions' Baltimore facility were safe and met quality specifications.